Compounds > c.i. 42510
Page last updated: 2024-08-21

c.i. 42510 and methotrexate

c.i. 42510 has been researched along with methotrexate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Baradaran, B; Deldar Abad Paskeh, M; Hashemi, M; Jazayeri, SM; Khodadadi, E; Kiani, F; Lanjanian, H; Maghsoudloo, M; Maleki, M; Masoudi-Nejad, A; Mokhtarzadeh, A; MotieGhader, H; Nematzadeh, S; Tabrizi-Nezhadi, P1

Other Studies

1 other study(ies) available for c.i. 42510 and methotrexate

ArticleYear
Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug-gene interaction networks analysis.
    Scientific reports, 2022, 06-08, Volume: 12, Issue:1

    Topics: Carcinoma, Non-Small-Cell Lung; Dexamethasone; Doxorubicin; Drug Repositioning; Female; Gene Expression Profiling; Gene Regulatory Networks; Humans; Lung Neoplasms; Methotrexate; Rosaniline Dyes

2022